{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:56:09Z","timestamp":1773766569058,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":539,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1RO1 HL103931-02"],"award-info":[{"award-number":["1RO1 HL103931-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01 HL076491-055328"],"award-info":[{"award-number":["P01 HL076491-055328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01 HL087018-020001"],"award-info":[{"award-number":["P01 HL087018-020001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1P01 HL098055-01"],"award-info":[{"award-number":["1P01 HL098055-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P50 HL077107-050004"],"award-info":[{"award-number":["P50 HL077107-050004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cleveland Clinic Clinical Research Unit of the Cleveland Clinic\/Case Western Reserve University","award":["1UL1RR024989"],"award-info":[{"award-number":["1UL1RR024989"]}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liposciences"},{"name":"Cleveland Heart Lab"},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jacc.2011.12.022","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T20:53:40Z","timestamp":1332190420000},"page":"1150-1158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Pulmonary Hypertension Associated With Advanced Systolic Heart Failure"],"prefix":"10.1016","volume":"59","author":[{"given":"Zhili","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen G.","family":"Borowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Moravec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.12.022_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2011.12.022_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"issue":"Suppl 12","key":"10.1016\/j.jacc.2011.12.022_bib3","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","article-title":"Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis","volume":"20","author":"Vallance","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2011.12.022_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jacc.2011.12.022_bib5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.022_bib6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.12.022_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","article-title":"Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition","volume":"29","author":"Wang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.12.022_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2009.10.034","article-title":"Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography","volume":"210","author":"Cavusoglu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2011.12.022_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.108.162768","article-title":"Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction","volume":"28","author":"Zeller","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.12.022_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCA.0b013e328323982f","article-title":"Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography","volume":"20","author":"Cavusoglu","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2011.12.022_bib11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.107.693986","article-title":"Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction","volume":"116","author":"Nicholls","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.022_bib12","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/ATVBAHA.107.147595","article-title":"Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure","volume":"27","author":"Duckelmann","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.12.022_bib13","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/eurheartj\/ehn360","article-title":"Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure","volume":"29","author":"Tang","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.12.022_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00380-003-0715-y","article-title":"High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level","volume":"18","author":"Saitoh","year":"2003","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacc.2011.12.022_bib15","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0024-3205(98)00225-2","article-title":"Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure","volume":"62","author":"Usui","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.jacc.2011.12.022_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.022_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2006.06.007","article-title":"Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential","volume":"113","author":"Krause","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2011.12.022_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00877920","article-title":"Endothelial control of vascular and myocardial function in heart failure","volume":"8","author":"Paulus","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2011.12.022_bib19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1096\/fj.04-3223fje","article-title":"Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension","volume":"19","author":"Pullamsetti","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2011.12.022_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.ATV.0000168414.06853.f0","article-title":"Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension","volume":"25","author":"Kielstein","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.12.022_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.2009.07658.x","article-title":"Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death","volume":"145","author":"Kato","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2011.12.022_bib22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2011.12.022_bib23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/ndt\/gfn716","article-title":"Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes","volume":"24","author":"Hanai","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2011.12.022_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cardfail.2010.09.003","article-title":"The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure","volume":"17","author":"Seljeflot","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2011.12.022_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.12.022_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.amjcard.2008.12.028","article-title":"Usefulness of isosorbide dinitrate and hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure","volume":"103","author":"Mullens","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.12.022_bib27","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.12.022_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2009.02.022","article-title":"Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database","volume":"157","author":"Khush","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.12.022_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hfc.2009.11.007","article-title":"Heart failure and pulmonary hypertension","volume":"6","author":"Shin","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2011.12.022_bib30","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.022_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/STROKEAHA.107.490631","article-title":"Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation","volume":"39","author":"Dayoub","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2011.12.022_bib32","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/01.CIR.0000158487.80483.09","article-title":"Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis","volume":"111","author":"Jacobi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.022_bib33","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/ATVBAHA.110.222638","article-title":"Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine","volume":"31","author":"Hu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.12.022_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardiores.2007.04.030","article-title":"Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury","volume":"75","author":"Stuhlinger","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2011.12.022_bib35","doi-asserted-by":"crossref","first-page":"H2212","DOI":"10.1152\/ajpheart.00224.2005","article-title":"Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts","volume":"289","author":"Chen","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2011.12.022_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/physiolgenomics.00022.2003","article-title":"Alterations of gene expression in failing myocardium following left ventricular assist device support","volume":"14","author":"Chen","year":"2003","journal-title":"Physiol Genomics"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:50:28Z","timestamp":1760014228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0735109712002434"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.12.022","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Hypertension Associated With Advanced Systolic Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}